Notice of Allowance

nveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

Intellectual property describes composition of matter claims governing Enveric’s lead clinical candidate,…

Ryan has been a financial writer for more than a decade, covering…

Aduro Clean Technologies, Inc. (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5) CEO Ofer…

Sometimes stock market performance doesn’t line up with the fundamentals of a…

D. Boral Capital is a premier global investment bank headquartered in New…

Major technological advances are often driven by market demand for solutions to…